ENDRA Life Sciences (NDRA) Tops Q3 EPS by 1c

ENDRA Life Sciences (NASDAQ: NDRA) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
• Docusign Inc. (DOCU) PT Raised to $58 at BofA Securities